Michael Gelband’s Clover Health Investments CLOV Stock Holding History

Michael Gelband’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Buy	+220,499	New	+$749K	0.01%	1030
2026 Q1	–	Sell	-59,157	Closed	-$139K	–	1618
2025 Q4	$139K	Buy	+59,157	New	+$162K	﹤0.01%	1420
2025 Q2	–	Sell	-58,798	Closed	-$211K	–	1528
2025 Q1	$211K	Sell	58,798 -146,154	-71%	-$587K	﹤0.01%	1289
2024 Q4	$646K	Buy	+204,952	New	+$732K	﹤0.01%	1074
2024 Q3	–	Sell	-86,143	Closed	-$106K	–	1676
2024 Q2	$106K	Buy	+86,143	New	+$77.3K	﹤0.01%	1426
2022 Q4	–	Sell	-430,563	Closed	-$732K	–	1699
2022 Q3	$732K	Buy	430,563 +30,276	+8%	+$79.3K	0.01%	1230
2022 Q2	$857K	Sell	400,287 -167,161	-29%	-$444K	0.01%	1151
2022 Q1	$2.01M	Buy	567,448 +248,547	+78%	+$721K	0.03%	778
2021 Q4	$1.19M	Buy	+318,901	New	+$1.96M	0.01%	981
2021 Q3	–	Sell	-111,670	Closed	-$1.49M	–	2177
2021 Q2	$1.49M	Sell	111,670 -124,012	-53%	-$1.22M	0.02%	810
2021 Q1	$1.78M	Buy	+235,682	New	+$2.66M	0.03%	611

Other funds holding CLOV

California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Michael Gelband's CLOV Position: Q2 2026 in Review

Michael Gelband opened a new position in Clover Health Investments (CLOV) in Q2 2026: 220,499 shares worth $1.16M. The stake represents 0.01% of the portfolio and ranks #1030 among its holdings. This is a return to the name: Michael Gelband previously reported a position in CLOV as recently as Q4 2025.

Michael Gelband first reported a position in CLOV in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.01M in Q1 2022. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Michael Gelband held 220,499 shares of Clover Health Investments worth $1.16M as of Q2 2026.
Clover Health Investments was a new Michael Gelband position in Q2 2026.
Clover Health Investments made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #1030 holding.
Michael Gelband first reported a position in Clover Health Investments in Q1 2021 and has held it in 11 quarters since.
Michael Gelband's Clover Health Investments position peaked at $2.01M in Q1 2022.
225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.